{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:34:01Z","timestamp":1762983241229,"version":"3.45.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.euros.2024.01.003","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T18:15:00Z","timestamp":1708712100000},"page":"26-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Disparities in the Delivery of Prostate Cancer Survivorship Care in the USA: A Claims-based Analysis of Urinary Adverse Events and Erectile Dysfunction Among Prostate Cancer Survivors"],"prefix":"10.1016","volume":"62","author":[{"given":"Nnenaya","family":"Mmonu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Kamdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"3rd","given":"Mack","family":"Roach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danil","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sondra","family":"Zabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Breyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2024.01.003_b0005","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euros.2024.01.003_b0010","unstructured":"Howlader N, Noone AM, Krapcho M, et al, editors. SEER cancer statistics review (CSR) 1975\u20132018. Bethesda, MD: National Cancer Institute; 2021. https:\/\/seer.cancer.gov\/archive\/csr\/1975_2018\/index.html."},{"key":"10.1016\/j.euros.2024.01.003_b0015","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.2016.72.1373","article-title":"Going beyond being lost in transition: a decade of progress in cancer survivorship","volume":"35","author":"Nekhlyudov","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2024.01.003_b0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.publhealth.27.021405.102103","article-title":"Health disparities and health equity: concepts and measurement","volume":"27","author":"Braveman","year":"2006","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.euros.2024.01.003_b0025","first-page":"211","article-title":"Cancer statistics for African Americans, 2019","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euros.2024.01.003_b0030","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1002\/cam4.2149","article-title":"Barriers to obtaining prostate multi-parametric magnetic resonance imaging in African-American men on active surveillance for prostate cancer","volume":"8","author":"Walton","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.euros.2024.01.003_b0035","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1200\/OP.22.00147","article-title":"Understanding the role of urology practice organization and racial composition in prostate cancer treatment disparities","volume":"19","author":"Agochukwu-Mmonu","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.euros.2024.01.003_b0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2014.08.061","article-title":"Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both","volume":"67","author":"Jarosek","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.01.003_b0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000484616","article-title":"Urinary incontinence, patient satisfaction, and decisional regret after prostate cancer treatment: a French national study","volume":"100","author":"Albkri","year":"2018","journal-title":"Urol Int"},{"key":"10.1016\/j.euros.2024.01.003_b0050","first-page":"225","article-title":"American Cancer Society prostate cancer survivorship care guidelines","volume":"64","author":"Skolarus","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euros.2024.01.003_b0055","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.juro.2016.10.091","article-title":"Urinary diversion for severe urinary adverse events of prostate radiation: results from a multi-institutional study","volume":"197","author":"Bassett","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2024.01.003_b0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12874-017-0367-8","article-title":"Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments","volume":"17","author":"Bolch","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.euros.2024.01.003_b0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.eururo.2014.09.029","article-title":"Understanding long-term urinary adverse events after treatment of localized prostate cancer: a key tool in informed decision-making","volume":"67","author":"Laviana","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.01.003_b0070","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.annepidem.2014.06.099","article-title":"Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage","volume":"24","author":"Chawla","year":"2014","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.euros.2024.01.003_b0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.euros.2024.01.003_b0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canep.2019.01.019","article-title":"Insurance status as a modifier of the association between race and stage of prostate cancer diagnosis in Florida during 1995 and 2013","volume":"59","author":"Ramirez","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.euros.2024.01.003_b0085","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.14694\/EdBook_AM.2015.35.e583","article-title":"Assuring quality cancer survivorship care: we\u2019ve only just begun","volume":"35","author":"Mayer","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.euros.2024.01.003_b0090","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/JU.0000000000000618","article-title":"Use of surgery for post-prostatectomy incontinence","volume":"203","author":"Nelson","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2024.01.003_b0095","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/nau.22790","article-title":"Utilization of surgical procedures and racial disparity in the treatment of urinary incontinence after prostatectomy","volume":"35","author":"Gupta","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.euros.2024.01.003_b0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.eururo.2016.10.036","article-title":"Racial variation in patient-reported outcomes following treatment for localized prostate cancer: results from the CEASAR study","volume":"72","author":"Tyson","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.01.003_b0105","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/end.2011.0507","article-title":"Functional outcomes in African-Americans after robot-assisted radical prostatectomy","volume":"26","author":"DeCastro","year":"2012","journal-title":"J Endourol"},{"key":"10.1016\/j.euros.2024.01.003_b0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.juro.2016.08.080","article-title":"Rectourethral fistulas secondary to prostate cancer treatment: management and outcomes from a multi-institutional combined experience","volume":"197","author":"Harris","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2024.01.003_b0115","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0360-3016(02)03742-2","article-title":"Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer","volume":"54","author":"Huang","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euros.2024.01.003_b0120","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.urology.2007.01.044","article-title":"Rectourethral fistula after combination radiotherapy for prostate cancer","volume":"69","author":"Marguet","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.euros.2024.01.003_b0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1464-410X.2004.04550.x","article-title":"Devastating complications after brachytherapy in the treatment of prostate adenocarcinoma","volume":"93","author":"Moreira","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2024.01.003_b0130","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-5347(05)67817-2","article-title":"Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer","volume":"163","author":"Pisansky","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2024.01.003_b0135","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/codi.14943","article-title":"Racial disparities after stoma construction in colorectal surgery","volume":"22","author":"Sharp","year":"2020","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.euros.2024.01.003_b0140","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1377\/hlthaff.2011.1365","article-title":"Black patients more likely than Whites to undergo surgery at low-quality hospitals in segregated regions","volume":"32","author":"Dimick","year":"2013","journal-title":"Health Aff"},{"key":"10.1016\/j.euros.2024.01.003_b0145","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.2105\/AJPH.2015.302903","article-title":"Implicit racial\/ethnic bias among health care professionals and its influence on health care outcomes: a systematic review","volume":"105","author":"Hall","year":"2015","journal-title":"Am J Public Health"},{"key":"10.1016\/j.euros.2024.01.003_b0150","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11255-007-9247-1","article-title":"Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment","volume":"40","author":"Akbal","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euros.2024.01.003_b0155","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.soncn.2011.07.006","article-title":"Erectile dysfunction and urinary incontinence after prostate cancer treatment","volume":"27","author":"Mirza","year":"2011","journal-title":"Semin Oncol Nurs"},{"issue":"Suppl 1","key":"10.1016\/j.euros.2024.01.003_b0160","first-page":"17","article-title":"Management of erectile dysfunction and LUTS\/incontinence: the two most common, long-term side effects of prostate cancer treatment","volume":"27","author":"Shabataev","year":"2020","journal-title":"Can J Urol"},{"key":"10.1016\/j.euros.2024.01.003_b0165","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/archsurg.139.9.992","article-title":"Racial discrepancies in the outcome of patients with hepatocellular carcinoma","volume":"139","author":"Harrison","year":"2004","journal-title":"Arch Surg"},{"key":"10.1016\/j.euros.2024.01.003_b0170","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1001\/jama.287.16.2106","article-title":"Survival of Blacks and Whites after a cancer diagnosis","volume":"287","author":"Bach","year":"2002","journal-title":"JAMA"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616832400209X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616832400209X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:12:25Z","timestamp":1762978345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266616832400209X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":34,"alternative-id":["S266616832400209X"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2024.01.003","relation":{},"ISSN":["2666-1683"],"issn-type":[{"type":"print","value":"2666-1683"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in the Delivery of Prostate Cancer Survivorship Care in the USA: A Claims-based Analysis of Urinary Adverse Events and Erectile Dysfunction Among Prostate Cancer Survivors","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2024.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}